Table 2 Univariate and multivariate analyses of predictive factors of not-receiving the anti-osteoporosis medication 1 year after hip fracture
Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
Treatment group (n = 148) | No treatment group (n = 320) | P-value | Odds ratio | 95% confidence interval | P-value | |
Age (years) | 77.8 ± 9.1 | 78.9 ± 10.0 | 0.272 | |||
Sex; male, n (%) | 25 (16.9) | 88 (27.5) | 0.014 | 1.8 | 1.1 – 3.0 | 0.017 |
Body mass index (kg/m2) | 22.1 ± 4.0 | 22.6 ± 4.4 | 0.246 | |||
Charlson comorbidity index, n (%) | ||||||
- 1–4 | 82 (55.4) | 142 (44.4) | ||||
- ≥ 5 | 66 (44.6) | 178 (55.6) | 0.027 | 1.5 | 1.0 – 2.3 | 0.045 |
Level of education, n (%) | ||||||
- Secondary school or below | 113 (76.4) | 276 (86.2) | 0.009 | 2.0 | 1.2 – 3.3 | 0.007 |
- Bachelor’s degree or higher | 35 (23.6) | 44 (13.8) | ||||
Type of hip fracture, n (%) | ||||||
- Femoral neck fracture | 76 (51.4) | 169 (52.8) | ||||
- Intertrochanteric fracture | 68 (45.9) | 147 (45.9) | 0.974 | |||
- Subtrochanteric fracture | 4 (2.7) | 4 (1.3) | 0.267 | |||
Pre-fracture ambulatory status, n (%) | ||||||
- Bedridden | 3 (2.0) | 10 (3.1) | ||||
- Indoor dependent | 10 (6.8) | 28 (8.8) | 0.817 | |||
- Outdoor dependent | 2 (1.4) | 9 (2.8) | 0.769 | |||
- Indoor independent | 45 (30.4) | 86 (26.9) | 0.445 | |||
- Outdoor independent | 88 (59.5) | 187 (58.4) | 0.502 | |||
Use of assistive device, n (%) | ||||||
- No | 81 (54.7) | 177 (55.3) | 0.906 | |||
- Yes | 67 (45.3) | 143 (44.7) | ||||
Healthcare reimbursement coverage, n (%) | ||||||
- Yes | 113 (76.4) | 240 (75.0) | 0.752 | |||
- No or self-pay | 35 (23.6) | 80 (25.0) | ||||